Search - tctmd.com

Displaying 681 - 700 of 989

Sort: Relevancy | Date

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

Presentation NY Valves 2024

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Presenter: Philippe Pibarot

June 06, 2024

Presentation NY Valves 2024

Case Presentation

Presenter: Sahil Khera

June 06, 2024

Presentation NY Valves 2024

The Design of the Navitor Vision Valve

Presenter: Hemal Gada

June 06, 2024

Presentation NY Valves 2024

Tips and Tricks for TAVR Explantation

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

Presentation NY Valves 2024

Redo TAVR Through Embolized Evolut FX Valve

Presenter: Richard Tanner

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

Presenter: Vivek Patel

June 06, 2024

Presentation NY Valves 2024

Comparison of Outcomes Between Concomitant Surgery of the Aortic and Mitral Valves Versus Transcatheter Aortic and Mitral Interventions Within One Year

Presenter: Michael Cinelli

June 06, 2024

Presentation NY Valves 2024

What is the Status of Valve-in-Valve TAVR in a Bioprosthesis?

Presenter: Gilbert H. L. Tang

June 06, 2024

Presentation NY Valves 2024

Redo TAVR in a Young Patient With Congenital AV Disease

Presenter: Richard Tanner

June 06, 2024

Presentation NY Valves 2024

Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials

Presenter: Errol Christopher Moras

June 06, 2024

Presentation NY Valves 2024

CT Planning With Redo TAV App Guiding Strategy to Prevent Coronary Obstruction for TAV-in-TAV Procedure

Presenter: Supawat Ratanapo

June 06, 2024

Presentation NY Valves 2024

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

Presenter: Supawat Ratanapo

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

J-Valve

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

Presenter: Annette Maznyczka

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Advertisement

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Case Presentation

The Design of the Navitor Vision Valve

Tips and Tricks for TAVR Explantation

SAVR After TAVR: A Dangerous Epidemic?

Redo TAVR Through Embolized Evolut FX Valve

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

Comparison of Outcomes Between Concomitant Surgery of the Aortic and Mitral Valves Versus Transcatheter Aortic and Mitral Interventions Within One Year

What is the Status of Valve-in-Valve TAVR in a Bioprosthesis?

Redo TAVR in a Young Patient With Congenital AV Disease

Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials

CT Planning With Redo TAV App Guiding Strategy to Prevent Coronary Obstruction for TAV-in-TAV Procedure

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

SAVR Will Have a Longer Lasting Durability Than TAVR

J-Valve

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

TAVR Will Have a Longer Lasting Durability Than SAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content